top of page
Ovarian Cancer
1 in 5 women will develop a pelvic mass in their lifetime. Doctors won't know if it is ovarian cancer or non-cancer mass until surgical removal of the mass for pathology.
Next-gen ovarian cancer blood test
ProSeek Bio is developing ovarian cancer blood tests for differential diagnosis of pelvic mass and screening of high risk women, building on the discovery research from founder's previous laboratory at QIMR Berghofer Medical Research Institute.
​
To bring ovarian cancer glycoform biomarker panel blood tests to the clinical pathology laboratory as fast as possible, ProSeek Bio is developing international strategic partnerships. Please contact us for further information on partnering.
bottom of page